SINO BIOPHARMACEUTICAL LIMITED

Analyst Reco. Sino Biopharmaceutical Limited

Stocks

1177

KYG8167W1380

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 01:09:47 15/06/2026 pm IST			5-day change	1st Jan Change
4.790 ^HKD	+1.91%		+5.74%	-22.49%

06:53am	Sino Biopharmaceutical Plans HK$2 Billion Stock Buyback	MT
30/05	Sino Biopharmaceutical Limited Announces Approval For Marketing of Naldemedine For Opioid-Induced Constipation In Adults	CI

Analyst Reco.

27/03	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.67 From HK$9.17, Keeps at Buy	MT
14/25/14	Sino Biopharmaceutical Limited Announces TQB2102 "Her2 BISPECific ADC" Included in the Breakthrough Therapeutic Designation Process	CI
13/25/13	Sino Biopharmaceutical says TQB2102 included in breakthrough therapeutic designation process in China	RE
19/25/19	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.17 From HK$7.69, Keeps at Buy	MT
25/25/25	Huachuang Securities Starts Sino Biopharmaceutical at Add with HK$9.35 Price Target	MT
16/25/16	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.69 From HK$5.52, Keeps at Buy	MT
21/25/21	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$5.52 From HK$6.42, Keeps at Buy	MT
14/24/14	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.42 From HK$6.16, Keeps at Buy	MT
15/24/15	Nomura Adjusts Sino Biopharmaceutical’s Price Target to HK$6.16 From HK$6.63, Keeps at Buy	MT
02/23/02	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$6.63 From HK$7.43, Keeps at Buy	MT
10/23/10	Nomura Adjusts Sinobiopharma's Price Target to HK$7.43 From HK$7.78, Keeps at Buy	MT
25/22/25	UBS Adjusts Sino Biopharmaceutical's Price Target to HK$7.5 From HK$8, Keeps at Buy	MT
24/22/24	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$7.78 From HK$8.19, Keeps at Buy	MT
11/22/11	Nomura Adjust Sino Biopharma’s Price Target to HK$8.19 From HK$8.53, Keeps at Buy	MT
06/22/06	UBS Adjusts Sino Biopharmaceutical's Price Target to HK$8 From HK$11.6, Keeps at Buy	MT
01/22/01	Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.53 From HK$9.38, Keeps at Buy	MT
30/21/30	SINO BIOPHARMACEUTICAL : Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$9.3 From HK$8.97, Keeps at Buy	MT

No results match your criteria

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Sino Biopharm's Bullish Market Momentum

Sino Biopharm's Bullish Market Momentum

February 04, 2026 at 02:45 pm IST

Sino Biopharma CEO on China's Rapid Clinical Trial Growth

January 23, 2026 at 02:22 am IST

Sino Biopharma CEO on China's Rapid Clinical Trial Growth

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrows Top Investments!

SEIZE THE OFFER!